These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 26305551
1. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets. Shah T, Krishnamachary B, Wildes F, Mironchik Y, Kakkad SM, Jacob D, Artemov D, Bhujwalla ZM. Oncotarget; 2015 Sep 29; 6(29):28104-19. PubMed ID: 26305551 [Abstract] [Full Text] [Related]
7. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia. Aquino-Gálvez A, González-Ávila G, Delgado-Tello J, Castillejos-López M, Mendoza-Milla C, Zúñiga J, Checa M, Maldonado-Martínez HA, Trinidad-López A, Cisneros J, Torres-Espíndola LM, Hernández-Jiménez C, Sommer B, Cabello-Gutiérrez C, Gutiérrez-González LH. Oncol Rep; 2016 Jan 29; 35(1):577-83. PubMed ID: 26548300 [Abstract] [Full Text] [Related]
9. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells. Fuady JH, Gutsche K, Santambrogio S, Varga Z, Hoogewijs D, Wenger RH. Oncotarget; 2016 May 24; 7(21):31153-65. PubMed ID: 27105516 [Abstract] [Full Text] [Related]
10. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways. Yan Y, Liu F, Han L, Zhao L, Chen J, Olopade OI, He M, Wei M. J Exp Clin Cancer Res; 2018 Oct 19; 37(1):256. PubMed ID: 30340507 [Abstract] [Full Text] [Related]
19. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, Wu HK, Saigal B, Zweidler-McKay PA, Heymach JV. Oncogene; 2010 May 20; 29(20):2938-49. PubMed ID: 20208561 [Abstract] [Full Text] [Related]
20. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Harashima N, Takenaga K, Akimoto M, Harada M. Oncotarget; 2017 Jun 27; 8(26):42887-42900. PubMed ID: 28476028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]